Stockreport

Theravance Stock Declines Around 17% in Three Months: Here's Why [Yahoo! Finance]

Theravance Biopharma, Inc. - Ordinary Shares  (TBPH) 
Last theravance biopharma, inc. - ordinary shares earnings: 2/24 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.theravance.com/investor-relations
PDF follows a major setback involving its lead pipeline candidate, ampreloxetine, a once-daily norepinephrine reuptake inhibitor. Failure of Phase III CYPRESS Study Weighs [Read more]